rethinkPeptides Search
Menu
Research citation

The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.

Critical care (London, England), 17(1), R8

Citation

Wu, Jianfeng; Zhou, Lixin; Liu, Jiyun; Ma, Gang; Kou, Qiuye; He, Zhijie; Chen, Juan; Ou-Yang, Bin; Chen, Minying; Li, Yinan; Wu, Xiaoqin; Gu, Baochun; Chen, Lei; Zou, Zijun; Qiang, Xinhua; Chen, Yuanyuan; Lin, Aihua; Zhang, Guanrong; Guan, Xiangdong. (2013). The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.. Critical care (London, England), 17(1), R8. https://doi.org/10.1186/cc11932